Work

B-386 Therapeutic Drug Monitoring (TDM) Assays to Quantify Guselkumab and Anti-Guselkumab Antibodies in Individuals Treated with IL23 Inhibitor Guselkumab for Chronic Autoimmune Diseases

Year: 2026

Type: conference-abstract

Source: Clinical Chemistry

DOI: 10.1093/clinchem/hvag086.654

Authors: Kelly Chun, Brandon Bauer, Monique Bastidas, Hui Han, Wayne Galdamez, Michael Zikry, Jane Yang, Kelly Chun

Institutions: LabCorp (United States), Optical Physics Company (United States), StereoVision Imaging (United States), University of Calabar

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7219869804

Cites:

Cited by:

Related to: